News for Lexicon Pharmaceuticals, Inc. (LXRX)

THE WOODLANDS, Texas, March 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. ( LXRX) today announced the Company will release its fourth quarter and

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Lexicon Pharmaceuticals, Inc. (LXRX), Monday announced topline results from the PROGRESS Phase 2b study evaluating pilavapadin in adult patients with moderate to severe diabetic peripheral neuropathic pain or DPNP.

**media[555306]**

**media[554820]**

Event will feature insights on LX9211, Lexicon's novel, investigational, non-opioid treatment, as well as expert panel and Q&A session on DPNP THE WOODLANDS,

**media[511554]**

**media[504192]**

Lexicon Appoints Scott Coiante as Chief Financial Officer

THE WOODLANDS, Texas, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. ( LXRX) today announced the appointment of Scott Coiante as senior vice

The FDA has declined to approve Lexicon's (LXRX) drug Zynquista as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes and chronic kidney disease.

**media[498227]**

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Thomas Andrew Garner has been appointed Chief Commercial Officer, effective today. Mr. Garner w

Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer

The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step into the final month of the year, let's take a look at the biotech companies whose drugs are under regulatory review in the U.

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Teva Pharma Industries Ltd ADR, Viatris Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com

Shares of Charter Communications, Inc. CHTR rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS and rev...

This week, once again, companies across the biotech sector continued to re-evaluate their pipelines and trim their workforces in a bid to conserve cash and extend their financial runway.

The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET)..